Correlation Between Ultragenyx and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Ultragenyx and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultragenyx and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultragenyx and Blueprint Medicines Corp, you can compare the effects of market volatilities on Ultragenyx and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultragenyx with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultragenyx and Blueprint Medicines.
Diversification Opportunities for Ultragenyx and Blueprint Medicines
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ultragenyx and Blueprint is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Ultragenyx and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Ultragenyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultragenyx are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Ultragenyx i.e., Ultragenyx and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Ultragenyx and Blueprint Medicines
Given the investment horizon of 90 days Ultragenyx is expected to under-perform the Blueprint Medicines. But the stock apears to be less risky and, when comparing its historical volatility, Ultragenyx is 1.33 times less risky than Blueprint Medicines. The stock trades about -0.32 of its potential returns per unit of risk. The Blueprint Medicines Corp is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 8,440 in Blueprint Medicines Corp on August 24, 2024 and sell it today you would earn a total of 1,317 from holding Blueprint Medicines Corp or generate 15.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ultragenyx vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Ultragenyx |
| Blueprint Medicines Corp |
Ultragenyx and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ultragenyx and Blueprint Medicines
The main advantage of trading using opposite Ultragenyx and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultragenyx position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Ultragenyx vs. X4 Pharmaceuticals | Ultragenyx vs. Terns Pharmaceuticals | Ultragenyx vs. Day One Biopharmaceuticals | Ultragenyx vs. PDS Biotechnology Corp |
| Blueprint Medicines vs. Lyra Therapeutics | Blueprint Medicines vs. Hookipa Pharma | Blueprint Medicines vs. Cingulate Warrants | Blueprint Medicines vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |